Recombinant Bifidobacterium infantis galactokinase (GalK), E. coli

Cat. No.: XET002Q

Recombinant Bifidobacterium infantis galactokinase (GalK), E. coli

Synonym: GalK; GALK1; Galactose kinase

  • Enzyme Commission Number: 2.7.1.6
Product Size
5 units; 20 units; 100 units
Price
Datasheet
MSDS
Properties
Description
It is an recombinant Bifidobacterium infantis galactokinase (GalK) produced in E. coli. This product can be used to study the mode of action of the enzyme and its potential inhibitors, and can also be used as a glycoengineering tool to modify glycoproteins in vitro.
Molecular Weight
43 kDa
Purity
>95%, determined by SDS-PAGE.
Unit Definition
One unit will catalyze the formation of 1 μmol Gal-1-P from galactose and ATP per minute at 37°C.
Source
Bifidobacterium infantis
Form
Lyophilized powder
Applications
Study the mode of action of the enzyme and its potential inhibitors and as a glycoengineering tool to modify glycoproteins in vitro.
Storage
Store at -20°C.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.